Allmed Medical Products Co Ltd Class A (002950) - Net Assets
Based on the latest financial reports, Allmed Medical Products Co Ltd Class A (002950) has net assets worth CN¥3.75 Billion CNY (≈ $548.53 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.35 Billion ≈ $783.35 Million USD) and total liabilities (CN¥1.60 Billion ≈ $234.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 002950 financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥3.75 Billion |
| % of Total Assets | 70.02% |
| Annual Growth Rate | 16.6% |
| 5-Year Change | 17.96% |
| 10-Year Change | 246.82% |
| Growth Volatility | 18.83 |
Allmed Medical Products Co Ltd Class A - Net Assets Trend (2014–2024)
This chart illustrates how Allmed Medical Products Co Ltd Class A's net assets have evolved over time, based on quarterly financial data. Also explore 002950 current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Allmed Medical Products Co Ltd Class A (2014–2024)
The table below shows the annual net assets of Allmed Medical Products Co Ltd Class A from 2014 to 2024. For live valuation and market cap data, see Allmed Medical Products Co Ltd Class A market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥3.45 Billion ≈ $504.56 Million |
+7.38% |
| 2023-12-31 | CN¥3.21 Billion ≈ $469.86 Million |
+2.55% |
| 2022-12-31 | CN¥3.13 Billion ≈ $458.16 Million |
+13.77% |
| 2021-12-31 | CN¥2.75 Billion ≈ $402.71 Million |
-5.85% |
| 2020-12-31 | CN¥2.92 Billion ≈ $427.74 Million |
+41.96% |
| 2019-12-31 | CN¥2.06 Billion ≈ $301.32 Million |
+55.80% |
| 2018-12-31 | CN¥1.32 Billion ≈ $193.40 Million |
+20.31% |
| 2017-12-31 | CN¥1.10 Billion ≈ $160.75 Million |
+7.87% |
| 2016-12-31 | CN¥1.02 Billion ≈ $149.03 Million |
+2.44% |
| 2015-12-31 | CN¥994.18 Million ≈ $145.48 Million |
+33.97% |
| 2014-12-31 | CN¥742.08 Million ≈ $108.59 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Allmed Medical Products Co Ltd Class A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 570.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥2.05 Billion | 59.58% |
| Common Stock | CN¥633.27 Million | 18.43% |
| Other Comprehensive Income | CN¥302.31 Million | 8.80% |
| Other Components | CN¥453.37 Million | 13.19% |
| Total Equity | CN¥3.44 Billion | 100.00% |
Allmed Medical Products Co Ltd Class A Competitors by Market Cap
The table below lists competitors of Allmed Medical Products Co Ltd Class A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Suzhou Jinfu New Material Co
SHE:300128
|
$1.31 Billion |
|
Shenzhen Tatfook Tech
SHE:300134
|
$1.31 Billion |
|
Cibus Nordic Real Estate AB (publ)
ST:CIBUS
|
$1.31 Billion |
|
JiangSu Jin Tong Ling Fluid Mach
SHE:300091
|
$1.31 Billion |
|
Labrador Iron Ore Royalty Corp
TO:LIF
|
$1.31 Billion |
|
Nanjing Xinjiekou Department Store Co Ltd
SHG:600682
|
$1.31 Billion |
|
OC OERL.CORP ADR 2 SF 1
F:OBH0
|
$1.31 Billion |
|
Weibo Corporation
F:2WBA
|
$1.31 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Allmed Medical Products Co Ltd Class A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,187,229,153 to 3,436,525,341, a change of 249,296,188 (7.8%).
- Net income of 368,679,147 contributed positively to equity growth.
- Dividend payments of 44,105,083 reduced retained earnings.
- Share repurchases of 97,893,977 reduced equity.
- Other comprehensive income increased equity by 302,309,265.
- Other factors decreased equity by 279,693,164.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥368.68 Million | +10.73% |
| Dividends Paid | CN¥44.11 Million | -1.28% |
| Share Repurchases | CN¥97.89 Million | -2.85% |
| Other Comprehensive Income | CN¥302.31 Million | +8.8% |
| Other Changes | CN¥-279.69 Million | -8.14% |
| Total Change | CN¥- | 7.82% |
Book Value vs Market Value Analysis
This analysis compares Allmed Medical Products Co Ltd Class A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.36x to 2.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥1.25 | CN¥14.17 | x |
| 2015-12-31 | CN¥1.69 | CN¥14.17 | x |
| 2016-12-31 | CN¥1.73 | CN¥14.17 | x |
| 2017-12-31 | CN¥1.94 | CN¥14.17 | x |
| 2018-12-31 | CN¥2.34 | CN¥14.17 | x |
| 2019-12-31 | CN¥3.24 | CN¥14.17 | x |
| 2020-12-31 | CN¥4.60 | CN¥14.17 | x |
| 2021-12-31 | CN¥4.35 | CN¥14.17 | x |
| 2022-12-31 | CN¥4.90 | CN¥14.17 | x |
| 2023-12-31 | CN¥4.91 | CN¥14.17 | x |
| 2024-12-31 | CN¥5.50 | CN¥14.17 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Allmed Medical Products Co Ltd Class A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.73%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.08%
- • Asset Turnover: 0.66x
- • Equity Multiplier: 1.47x
- Recent ROE (10.73%) is below the historical average (18.68%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 27.36% | 13.15% | 0.86x | 2.41x | CN¥125.91 Million |
| 2015 | 15.99% | 9.90% | 0.86x | 1.88x | CN¥58.82 Million |
| 2016 | 24.63% | 15.93% | 0.82x | 1.88x | CN¥147.39 Million |
| 2017 | 21.48% | 13.66% | 0.75x | 2.09x | CN¥124.94 Million |
| 2018 | 17.35% | 11.23% | 0.70x | 2.21x | CN¥96.52 Million |
| 2019 | 15.88% | 13.85% | 0.75x | 1.54x | CN¥120.64 Million |
| 2020 | 39.77% | 30.19% | 0.79x | 1.67x | CN¥866.46 Million |
| 2021 | 15.66% | 14.74% | 0.58x | 1.82x | CN¥155.92 Million |
| 2022 | 13.12% | 9.66% | 0.73x | 1.85x | CN¥96.68 Million |
| 2023 | 3.46% | 4.00% | 0.54x | 1.60x | CN¥-208.32 Million |
| 2024 | 10.73% | 11.08% | 0.66x | 1.47x | CN¥25.03 Million |
Industry Comparison
This section compares Allmed Medical Products Co Ltd Class A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,191,482,861
- Average return on equity (ROE) among peers: 1.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Allmed Medical Products Co Ltd Class A (002950) | CN¥3.75 Billion | 27.36% | 0.43x | $1.31 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $1.79 Billion | 0.80% | 1.04x | $517.97 Million |
| Blue Sail Medical Co Ltd (002382) | $984.34 Million | 4.77% | 0.96x | $1.04 Billion |
| Andon Health Co Ltd (002432) | $608.95 Million | -24.76% | 0.35x | $5.18 Billion |
| Guangzhou Improve Med Instrument (300030) | $963.72 Million | 1.16% | 0.81x | $382.31 Million |
| QITIAN Technology Group Co Ltd (300061) | $451.92 Million | 8.13% | 0.70x | $948.89 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $1.49 Billion |
| Truking Technology Ltd (300358) | $2.39 Billion | 1.73% | 0.74x | $1.04 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $552.62 Million | 6.63% | 0.13x | $810.58 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $574.90 Million | 6.24% | 0.48x | $2.53 Billion |
About Allmed Medical Products Co Ltd Class A
Allmed Medical Products Co., Ltd manufactures and sells wound care and nursing material products in China. The company's traditional wound care products include non-woven and woven gauze swabs, non-adherent pads, drain sponges, abdominal pads, fluffy sponges/bandages, woven gauze and nonwoven gauze balls, eye pads, cotton-filled exodontia sponges, packing strips, ribbon gauze, cotton-tipped appli… Read more